Advertisement
Screener

Minerva Neurosciences, Inc. (NERV) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Minerva Neurosciences, Inc. Stock-Based Compensation

Minerva Neurosciences, Inc. (NERV) reported Stock-Based Compensation of $10.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-07

  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.27M, a 662.14% increase year-over-year.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $8.71M, a 2830.50% increase year-over-year.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $459.03K, a 83.87% increase year-over-year.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $272.90K, a 11.31% decline year-over-year.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $1.33M, a 0.14% increase from fiscal 2024.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.33M, a 32.66% decline from fiscal 2023.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.97M, a 52.09% decline from fiscal 2022.
  • Minerva Neurosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $4.11M, a 21.27% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$2.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$10.98M
10-Q · filed 2026-08-07
$11.44M
derived: sum of 3 quarters · filed 2026-08-07
$11.72M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$8.71M
10-Q · filed 2026-05-05
$9.17M
derived: sum of 2 quarters · filed 2026-05-05
$9.44M
derived: sum of 3 quarters · filed 2026-05-05
$9.74M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$459.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
$731.92K
derived: sum of 2 quarters · filed 2026-03-11
$1.03M
derived: sum of 3 quarters · filed 2026-08-07
$1.33M
10-K · filed 2026-03-11
2025-09-30$272.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$571.12K
derived: sum of 2 quarters · filed 2026-08-07
$868.34K
10-Q · filed 2025-11-05
$1.12M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$298.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$595.45K
10-Q · filed 2026-08-07
$845.10K
derived: sum of 3 quarters · filed 2026-08-07
$1.15M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$297.23K
10-Q · filed 2026-05-05
$546.88K
derived: sum of 2 quarters · filed 2026-05-05
$854.59K
derived: sum of 3 quarters · filed 2026-05-05
$1.18M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$249.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
$557.36K
derived: sum of 2 quarters · filed 2026-03-11
$886.68K
derived: sum of 3 quarters · filed 2026-03-11
$1.33M
10-K · filed 2026-03-11
2024-09-30$307.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$637.03K
derived: sum of 2 quarters · filed 2025-11-05
$1.08M
10-Q · filed 2025-11-05
$1.69M
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$329.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$768.17K
10-Q · filed 2025-08-14
$1.38M
derived: sum of 3 quarters · filed 2025-08-14
$1.75M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$438.85K
10-Q · filed 2025-05-13
$1.05M
derived: sum of 2 quarters · filed 2025-05-13
$1.42M
derived: sum of 3 quarters · filed 2025-05-13
$2.03M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$611.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$983.01K
derived: sum of 2 quarters · filed 2025-02-25
$1.59M
derived: sum of 3 quarters · filed 2025-02-25
$1.97M
10-K · filed 2025-02-25
2023-09-30$371.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$980.86K
derived: sum of 2 quarters · filed 2024-11-05
$1.36M
10-Q · filed 2024-11-05
$2.31M
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30$608.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$985.37K
10-Q · filed 2024-08-06
$1.93M
derived: sum of 3 quarters · filed 2024-08-06
$2.97M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31$376.46K
10-Q · filed 2024-05-01
$1.32M
derived: sum of 2 quarters · filed 2024-05-01
$2.36M
derived: sum of 3 quarters · filed 2024-05-01
$3.43M
derived: sum of 4 quarters · filed 2024-05-01
2022-12-31$947.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$1.98M
derived: sum of 2 quarters · filed 2024-02-22
$3.06M
derived: sum of 3 quarters · filed 2024-02-22
$4.11M
10-K · filed 2024-02-22
2022-09-30$1.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$2.11M
derived: sum of 2 quarters · filed 2023-11-07
$3.16M
10-Q · filed 2023-11-07
$4.37M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$2.12M
10-Q · filed 2023-08-01
$3.33M
derived: sum of 3 quarters · filed 2023-08-01
$4.44M
derived: sum of 4 quarters · filed 2023-08-01
2022-03-31$1.05M
10-Q · filed 2023-05-15
$2.26M
derived: sum of 2 quarters · filed 2023-05-15
$3.37M
derived: sum of 3 quarters · filed 2023-05-15
$4.76M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$2.32M
derived: sum of 2 quarters · filed 2023-03-08
$3.70M
derived: sum of 3 quarters · filed 2023-03-08
$5.22M
10-K · filed 2023-03-08
2021-09-30$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$2.50M
derived: sum of 2 quarters · filed 2022-11-09
$4.01M
10-Q · filed 2022-11-09
$5.98M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$2.90M
10-Q · filed 2022-08-09
$4.86M
derived: sum of 3 quarters · filed 2022-08-09
$6.92M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.52M
10-Q · filed 2022-05-04
$3.48M
derived: sum of 2 quarters · filed 2022-05-04
$5.54M
derived: sum of 3 quarters · filed 2022-05-04
$9.02M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31$1.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$4.02M
derived: sum of 2 quarters · filed 2022-03-01
$7.51M
derived: sum of 3 quarters · filed 2022-03-01
$9.70M
10-K · filed 2022-03-01
2020-09-30$2.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$5.54M
derived: sum of 2 quarters · filed 2021-11-08
$7.74M
10-Q · filed 2021-11-08
$9.91M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$3.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02
$5.68M
10-Q · filed 2021-08-02
$7.85M
derived: sum of 3 quarters · filed 2021-08-02
$10.07M
derived: sum of 4 quarters · filed 2021-08-02
2020-03-31$2.20M
10-Q · filed 2021-05-12
$4.37M
derived: sum of 2 quarters · filed 2021-05-12
$6.59M
derived: sum of 3 quarters · filed 2021-05-12
$8.91M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$2.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
$4.39M
derived: sum of 2 quarters · filed 2021-03-08
$6.71M
derived: sum of 3 quarters · filed 2021-03-08
$9.17M
10-K · filed 2021-03-08
2019-09-30$2.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02
$4.54M
derived: sum of 2 quarters · filed 2020-11-02
$7.00M
10-Q · filed 2020-11-02
$8.91M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30$2.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03
$4.78M
10-Q · filed 2020-08-03
$6.69M
derived: sum of 3 quarters · filed 2020-08-03
$8.95M
derived: sum of 4 quarters · filed 2020-08-03
2019-03-31$2.46M
10-Q · filed 2020-05-04
$4.37M
derived: sum of 2 quarters · filed 2020-05-04
$6.63M
derived: sum of 3 quarters · filed 2020-05-04
$8.53M
derived: sum of 4 quarters · filed 2020-05-04
2018-12-31$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
$4.17M
derived: sum of 2 quarters · filed 2020-03-09
$6.07M
derived: sum of 3 quarters · filed 2020-03-09
$8.18M
10-K · filed 2020-03-09
2018-09-30$2.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
$4.16M
derived: sum of 2 quarters · filed 2019-11-04
$6.27M
10-Q · filed 2019-11-04
$7.53M
derived: sum of 4 quarters · filed 2019-11-04
2018-06-30$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
$4.01M
10-Q · filed 2019-08-05
$5.27M
derived: sum of 3 quarters · filed 2019-08-05
$6.50M
derived: sum of 4 quarters · filed 2019-08-05
2018-03-31$2.11M
10-Q · filed 2019-05-06
$3.37M
derived: sum of 2 quarters · filed 2019-05-06
$4.61M
derived: sum of 3 quarters · filed 2019-05-06
$5.84M
derived: sum of 4 quarters · filed 2019-05-06
2017-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$2.49M
derived: sum of 2 quarters · filed 2019-03-12
$3.72M
derived: sum of 3 quarters · filed 2019-03-12
$5.03M
10-K · filed 2019-03-12
2017-09-30$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
$2.47M
derived: sum of 2 quarters · filed 2018-11-05
$3.78M
10-Q · filed 2018-11-05
$4.79M
derived: sum of 4 quarters · filed 2018-11-05
2017-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$2.54M
10-Q · filed 2018-08-02
$3.55M
derived: sum of 3 quarters · filed 2018-08-02
$4.49M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.31M
10-Q · filed 2018-05-03
$2.32M
derived: sum of 2 quarters · filed 2018-05-03
$3.26M
derived: sum of 3 quarters · filed 2018-05-03
$4.09M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$1.95M
derived: sum of 2 quarters · filed 2018-03-12
$2.78M
derived: sum of 3 quarters · filed 2018-03-12
$3.57M
10-K · filed 2018-03-12
2016-09-30$935.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$1.77M
derived: sum of 2 quarters · filed 2017-11-06
$2.56M
10-Q · filed 2017-11-06
$3.25M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$832.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.62M
10-Q · filed 2017-08-03
$2.31M
derived: sum of 3 quarters · filed 2018-03-12
$2.94M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31$790.23K
10-Q · filed 2017-05-04
$1.48M
derived: sum of 2 quarters · filed 2018-03-12
$2.11M
derived: sum of 3 quarters · filed 2018-03-12
$2.66M
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$691.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$1.32M
derived: sum of 2 quarters · filed 2018-03-12
$1.87M
derived: sum of 3 quarters · filed 2018-03-12
$2.20M
10-K · filed 2018-03-12
2015-09-30$628.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$1.17M
derived: sum of 2 quarters · filed 2016-11-03
$1.51M
10-Q · filed 2016-11-03
$3.76M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$545.93K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$882.30K
10-Q · filed 2016-08-04
$3.13M
derived: sum of 3 quarters · filed 2017-03-13
$4.03M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$336.37K
10-Q · filed 2016-05-03
$2.58M
derived: sum of 2 quarters · filed 2017-03-13
$3.49M
derived: sum of 3 quarters · filed 2017-03-13
$18.00M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$2.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$3.15M
derived: sum of 2 quarters · filed 2017-03-13
$17.66M
derived: sum of 3 quarters · filed 2017-03-13
$17.97M
10-K · filed 2017-03-13
2014-09-30$903.07K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$15.42M
derived: sum of 2 quarters · filed 2015-11-05
$15.72M
10-Q · filed 2015-11-05
2014-06-30$14.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$14.82M
10-Q · filed 2015-08-05
2014-03-31$302.08K
10-Q · filed 2015-05-07
2013-12-31$655.72K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91